Toraft 1mg Tablet

Produktübersicht

About Toraft

Toraft is a medication containing the active ingredient Sirolimus, classified as mTOR Inhibitor Immunosuppressant. Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa).

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged ≥13 years.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Sirolimus, the active ingredient in Toraft, belongs to the mTOR Inhibitor Immunosuppressant class. 1 INDICATIONS AND USAGE Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged ≥13 years receiving renal transplants: Patients at low- to moderate-immunologic risk: Use initially with cyclosporine (CsA) and corticosteroids. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Toraft. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Toraft for extended periods without medical advice.